Li 2006a.

Methods	Six‐week randomised, double‐blind, double dummy trial
Participants	Patients with depressive disorder, with a score of at least 18 at Hamilton Depression Rating Scale (HDRS) and a score of 14 or greater at the Hamilton Anxiety Scale (HAM‐A)
Interventions	137 participants randomised to fluoxetine or reboxetine 64 patients in Reboxetine group and 68 in fluoxetine group completed the study Fluoxetine dose: 20 mg/day Reboxetine dose: 8 mg/day
Outcomes	Hamilton Depression Rating Scale (HDRS), Hamilton Rating Scale for Anxiety (HAM‐A)
Notes	Waiting for translation from Chinese to English (only abstract available in English)